Detailed information for compound 434964

Basic information

Technical information
  • TDR Targets ID: 434964
  • Name: N-(2-benzyl-1,3-benzoxazol-5-yl)-4-tert-butyl benzamide
  • MW: 384.47 | Formula: C25H24N2O2
  • H donors: 1 H acceptors: 2 LogP: 6.23 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C(c1ccc(cc1)C(C)(C)C)Nc1ccc2c(c1)nc(o2)Cc1ccccc1
  • InChi: 1S/C25H24N2O2/c1-25(2,3)19-11-9-18(10-12-19)24(28)26-20-13-14-22-21(16-20)27-23(29-22)15-17-7-5-4-6-8-17/h4-14,16H,15H2,1-3H3,(H,26,28)
  • InChiKey: MTURDHFQTNRLEO-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • N-(2-benzyl-1,3-benzoxazol-5-yl)-4-tert-butyl-benzamide
  • 4-tert-butyl-N-[2-(phenylmethyl)-1,3-benzoxazol-5-yl]benzamide
  • N-[2-(benzyl)-1,3-benzoxazol-5-yl]-4-tert-butyl-benzamide
  • AIDS-222965
  • AIDS222965
  • N-(2-Benzyl-benzooxazol-5-yl)-4-tert-butyl-benzamide

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trypanosoma brucei unspecified product 0.0019 0.0436 0.1763
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0436 0.1763
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0436 0.1763
Echinococcus multilocularis carboxylesterase 5A 0.0066 0.3904 1
Echinococcus granulosus terminal deoxycytidyl transferase rev1 0.0019 0.0436 0.0576
Trypanosoma brucei dihydrolipoyl dehydrogenase 0.0016 0.0224 0.0906
Loa Loa (eye worm) thioredoxin reductase 0.0047 0.2471 0.5869
Loa Loa (eye worm) hypothetical protein 0.0066 0.3904 1
Mycobacterium tuberculosis Probable reductase 0.0106 0.6877 0.8837
Trypanosoma brucei dihydrolipoamide dehydrogenase 0.0016 0.0224 0.0906
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0436 0.1763
Echinococcus granulosus dna polymerase kappa 0.0019 0.0436 0.0576
Chlamydia trachomatis dihydrolipoyl dehydrogenase 0.0016 0.0224 0.5
Mycobacterium tuberculosis NAD(P)H quinone reductase LpdA 0.0118 0.7753 1
Mycobacterium tuberculosis Probable membrane NADH dehydrogenase NdhA 0.0106 0.6877 0.8837
Mycobacterium tuberculosis Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras 0.0118 0.7753 1
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.0066 0.3904 0.3765
Brugia malayi glutathione reductase 0.0047 0.2471 0.6106
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0436 0.1763
Plasmodium vivax glutathione reductase, putative 0.0047 0.2471 1
Trypanosoma brucei DNA polymerase eta, putative 0.0019 0.0436 0.1763
Schistosoma mansoni rab geranylgeranyl transferase alpha subunit 0.0019 0.0436 0.0217
Mycobacterium leprae DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE 0.0118 0.7753 1
Loa Loa (eye worm) glutathione reductase 0.0047 0.2471 0.5869
Wolbachia endosymbiont of Brugia malayi dihydrolipoamide dehydrogenase E3 component 0.0016 0.0224 0.5
Mycobacterium tuberculosis Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB 0.0106 0.6877 0.8837
Echinococcus granulosus dna polymerase eta 0.0019 0.0436 0.0576
Loa Loa (eye worm) acetylcholinesterase 1 0.0066 0.3904 1
Mycobacterium ulcerans DNA polymerase IV 0.0019 0.0436 1
Mycobacterium tuberculosis Conserved hypothetical protein 0.0019 0.0436 0.0281
Echinococcus granulosus carboxylesterase 5A 0.0066 0.3904 1
Trypanosoma cruzi trypanothione reductase, putative 0.0047 0.2471 1
Toxoplasma gondii thioredoxin reductase 0.0047 0.2471 1
Plasmodium falciparum glutathione reductase 0.0047 0.2471 1
Loa Loa (eye worm) hypothetical protein 0.0066 0.3904 1
Leishmania major DNA polymerase eta, putative 0.0019 0.0436 0.0943
Echinococcus granulosus acetylcholinesterase 0.0066 0.3904 1
Trypanosoma cruzi DNA polymerase kappa, putative 0.0019 0.0436 0.0943
Echinococcus multilocularis terminal deoxycytidyl transferase rev1 0.0019 0.0436 0.0576
Trypanosoma brucei dihydrolipoamide dehydrogenase 0.0016 0.0224 0.0906
Trypanosoma brucei DNA polymerase IV, putative 0.0019 0.0436 0.1763
Mycobacterium tuberculosis Probable dehydrogenase 0.0106 0.6877 0.8837
Loa Loa (eye worm) carboxylesterase 0.0066 0.3904 1
Echinococcus multilocularis dna polymerase kappa 0.0019 0.0436 0.0576
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0436 0.1763
Trypanosoma cruzi DNA polymerase eta, putative 0.0019 0.0436 0.0943
Leishmania major DNA polymerase kappa, putative 0.0019 0.0436 0.0943
Brugia malayi Carboxylesterase family protein 0.0066 0.3904 1
Plasmodium falciparum thioredoxin reductase 0.0047 0.2471 1
Brugia malayi Thioredoxin reductase 0.0047 0.2471 0.6106
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0436 0.1763
Leishmania major DNA polymerase kappa, putative,DNA polymerase IV, putative 0.0019 0.0436 0.0943
Echinococcus multilocularis dna polymerase eta 0.0019 0.0436 0.0576
Trypanosoma brucei DNA polymerase IV, putative 0.0019 0.0436 0.1763
Schistosoma mansoni DNA polymerase eta 0.0019 0.0436 0.0217
Leishmania major trypanothione reductase 0.0047 0.2471 1
Mycobacterium tuberculosis Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) 0.0019 0.0436 0.0281
Trypanosoma cruzi DNA polymerase kappa, putative 0.0019 0.0436 0.0943
Echinococcus multilocularis acetylcholinesterase 0.0066 0.3904 1
Trypanosoma brucei trypanothione reductase 0.0047 0.2471 1
Schistosoma mansoni terminal deoxycytidyl transferase 0.0019 0.0436 0.0217
Brugia malayi ImpB/MucB/SamB family protein 0.0019 0.0436 0.0576
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0436 0.1763
Echinococcus multilocularis acetylcholinesterase 0.0066 0.3904 1
Mycobacterium tuberculosis Probable oxidoreductase 0.0118 0.7753 1
Brugia malayi ImpB/MucB/SamB family protein 0.0019 0.0436 0.0576
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0436 0.1763
Mycobacterium tuberculosis Putative ferredoxin reductase 0.0106 0.6877 0.8837
Brugia malayi Carboxylesterase family protein 0.0066 0.3904 1
Mycobacterium tuberculosis NADPH-dependent mycothiol reductase Mtr 0.0047 0.2471 0.2985
Giardia lamblia DINP protein human, muc B family 0.0019 0.0436 1
Trypanosoma cruzi DNA polymerase kappa, putative 0.0019 0.0436 0.0943
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0436 0.1763
Echinococcus multilocularis thioredoxin glutathione reductase 0.0047 0.2471 0.6106
Trichomonas vaginalis DNA polymerase IV / kappa, putative 0.0019 0.0436 1
Trypanosoma brucei dihydrolipoamide dehydrogenase, point mutation 0.0016 0.0224 0.0906
Echinococcus granulosus thioredoxin glutathione reductase 0.0047 0.2471 0.6106
Echinococcus granulosus acetylcholinesterase 0.0066 0.3904 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0436 0.1763
Trichomonas vaginalis DNA polymerase eta, putative 0.0019 0.0436 1
Mycobacterium ulcerans DNA polymerase IV 0.0019 0.0436 1
Mycobacterium tuberculosis Probable NADH dehydrogenase Ndh 0.0106 0.6877 0.8837
Trypanosoma cruzi DNA polymerase kappa, putative 0.0019 0.0436 0.0943
Wolbachia endosymbiont of Brugia malayi dihydrolipoamide dehydrogenase E3 component 0.0016 0.0224 0.5
Entamoeba histolytica deoxycytidyl transferase, putative 0.0019 0.0436 0.5
Trypanosoma brucei DNA polymerase IV, putative 0.0019 0.0436 0.1763
Treponema pallidum NADH oxidase 0.0016 0.0224 0.5
Plasmodium vivax thioredoxin reductase, putative 0.0047 0.2471 1

Activities

Activity type Activity value Assay description Source Reference
MIC (functional) = 25 ug ml-1 Antibacterial activity against Escherichia coli ATCC 23556 after 24 hrs by serial dilution method ChEMBL. 17337097
MIC (functional) = 25 ug ml-1 Antibacterial activity against Pseudomonas aeruginosa ATCC 10145 after 24 hrs by serial dilution method ChEMBL. 17337097
MIC (functional) = 25 ug ml-1 Antifungal activity against Candida krusei ATCC 6258 after 48 hrs by serial dilution method ChEMBL. 17337097
MIC (functional) = 25 ug ml-1 Antifungal activity against Candida glabrata after 48 hrs by serial dilution method ChEMBL. 17337097
MIC (functional) = 25 ug ml-1 Antibacterial activity against Escherichia coli ATCC 23556 after 24 hrs by serial dilution method ChEMBL. 17337097
MIC (functional) = 50 ug ml-1 Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by serial dilution method ChEMBL. 17337097
MIC (functional) = 50 ug ml-1 Antifungal activity against Candida albicans after 48 hrs by serial dilution method ChEMBL. 17337097
MIC (functional) = 50 ug ml-1 Antifungal activity against Candida albicans after 48 hrs by serial dilution method ChEMBL. 17337097
MIC (functional) = 200 ug ml-1 Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by serial dilution method ChEMBL. 17337097

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.